ABC
GBT

Associated Banc-Corp’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Associated Banc-Corp’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-26
Closed -$2K – 1067
2020
Q2 		$2K Buy
+26
New +$1.78K ﹤0.01% 803

Other funds holding GBT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Associated Banc-Corp's GBT Position: Q3 2020 in Review

Associated Banc-Corp sold out of Global Blood Therapeutics, Inc. (GBT) in Q3 2020, closing a stake of 26 shares — an estimated $2K sold.

Associated Banc-Corp first reported a position in GBT in Q2 2020 and held it in 1 quarter. The position peaked at $2K in Q2 2020. 229 funds tracked by Wall St. Rank hold GBT as of Q3 2020.

  • Associated Banc-Corp reported no remaining Global Blood Therapeutics, Inc. position as of Q3 2020 after selling out during the quarter.
  • Associated Banc-Corp sold 26 Global Blood Therapeutics, Inc. shares in Q3 2020, an estimated $2K.
  • Associated Banc-Corp first reported a position in Global Blood Therapeutics, Inc. in Q2 2020 and held it in 1 quarter.
  • Associated Banc-Corp's Global Blood Therapeutics, Inc. position peaked at $2K in Q2 2020.
  • 229 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q3 2020.

Based on Associated Banc-Corp's 13F filing for Q3 2020, filed 12 Nov 2020.